Combined modality treatment in the management of high-risk prostate cancer
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 59 (5) , 1352-1359
- https://doi.org/10.1016/j.ijrobp.2004.01.023
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413Journal of Clinical Oncology, 2003
- Conformal High Dose Rate Brachytherapy Improves Biochemical Control And Cause Specific Survival in Patients With Prostate Cancer And Poor Prognostic FactorsJournal of Urology, 2003
- Predicting Recurrence After Radical Prostatectomy for Patients With High Risk Prostate CancerJournal of Urology, 2003
- Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or aboveCancer, 2002
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/mlInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Seminal Vesicle Biopsy in Prostate Cancer StagingJournal of Urology, 1995
- A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, 1995